Chordia

190A.T

Tags: JP Medical - Pharmaceuticals

Chordia Therapeutics Inc. Price (190A.T)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

58,729,483

(4.0495)%

Market Cap of Chordia (190A.T)

Market cap:

As of , 190A.T has a market cap of . This makes 190A.T the 1795th most valuable company in the JP by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Chordia is focused on the oncology area, with its target areas ranging from exploratory research to Proof of Concept (POC). For subsequent business development, we will build a system that allows us to make the best choices for maximizing corporate value, such as out-licensing and joint development and sales. Read More

Previous Close Fetching Data...
Range $142-930
Market Cap 17.71B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Pharmaceuticals

ceo: Mr. Hiroshi Miyake Ph.D.
IPO Date: January, 01, 1970
Country: JP
Currency: JPY
Headquaters: No Data
Employees: No Data

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: